Clinical Trials Logo

Spinal Metastases clinical trials

View clinical trials related to Spinal Metastases.

Filter by:

NCT ID: NCT01365715 Completed - Spinal Metastases Clinical Trials

Preoperative Embolization in Surgical Treatment of Spinal Metastases.

Start date: May 2011
Phase: N/A
Study type: Interventional

The main purpose of this study is to assess the efficacy of preoperative embolization in decreasing operative blood loss, decreasing the need for intraoperative transfusion and facilitate surgical resection in metastatic spine surgery. Furthermore the study aims at describing the vascularity in a series of spinal metastasis, and to correlate this with perioperative blood loss.

NCT ID: NCT01347307 Completed - Meningioma Clinical Trials

Stereotactic Body Radiotherapy for Spine Tumors

Start date: September 2008
Phase: N/A
Study type: Interventional

This study will evaluate the local control rate as well as acute and late toxicity rates of stereotactic body radiotherapy (SBRT) for the treatment of spine metastases and benign spine tumors.

NCT ID: NCT01290562 Completed - Spinal Metastases Clinical Trials

Stereotactic Body Radiotherapy (SBRT) for Spinal/Para-Spinal Metastases (Spine SBRT)

Start date: June 2011
Phase: Phase 2
Study type: Interventional

Patients with new or recurrent spine metastases are currently treated with low doses of radiation delivered in up to ten treatments (wide-field radiation therapy). Stererotactic body radiotherapy (SBRT) is a technique in which high doses of radiation targeted precisely to the metastases to be treated are administered in a small number of sessions, thus reducing the radiation damage to the surrounding tissue and areas of the spine. The purpose of this study is to evaluate the efficacy of spine SBRT as an alternative to conventional radiation for patients with no prior radiation, prior radiation, and in the post-operative patient